Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
98.79%
-
Total 13F principal
-
$390,734,324
-
Principal change
-
+$5,103,675
-
Total reported market value
-
$385,595,690
-
Number of holders
-
43
-
Value change
-
+$5,416,627
-
Number of buys
-
13
-
Number of sells
-
12
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q2 2021
As of 30 Jun 2021 SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 had 43 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $390,734,324 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Radcliffe Capital Management, L.P., CAMDEN ASSET MANAGEMENT L P /CA, Opti Capital Management, LP, DeepCurrents Investment Group LLC, WOLVERINE ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., JPMORGAN CHASE & CO, OAKTREE CAPITAL MANAGEMENT LP, Invesco Ltd., and Polar Capital Holdings Plc.
This table shows 44 bond principal holders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price %
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.